Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6944)
All Articles published online
|
Publishing Process of This Article
|
Apr 14, 2013 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Li YJ, Zhu P, Liang Y, Yin WG, Xiao JH. Hepatitis B virus induces expression of cholesterol metabolism-related genes |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i14/2262.htm |
| Number | Citing Articles |
| 1 |
Y. Zhao, Sh. Tian, L. Yu, Zh. Zhang, W. Zhang. Analysis and Classification of Hepatitis Infections Using Raman Spectroscopy and Multiscale Convolutional Neural Networks. Journal of Applied Spectroscopy 2021; 88(2): 441 doi: 10.1007/s10812-021-01192-6
|
| 2 |
Angélica Luciana Nau, Júlia Cristina Soares, Maria Beatriz Cacese Shiozawa, Esther Buzaglo Dantas-Corrêa, Leonardo de Lucca Schiavon, Janaína Luz Narciso-Schiavon. Clinical and laboratory characteristics associated with dyslipidemia and liver steatosis in chronic HBV carriers. Revista da Sociedade Brasileira de Medicina Tropical 2014; 47(2): 158 doi: 10.1590/0037-8682-0009-2014
|
| 3 |
Jiaxuan Zhang, Ning Ling, Yu Lei, Mingli Peng, Peng Hu, Min Chen. Multifaceted Interaction Between Hepatitis B Virus Infection and Lipid Metabolism in Hepatocytes: A Potential Target of Antiviral Therapy for Chronic Hepatitis B. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.636897
|
| 4 |
Zhiyuan Gong, Zhiyong Yan, Wen Liu, Bing Luo. Oncogenic viruses and host lipid metabolism: a new perspective.
Journal of General Virology
2023; 104(6) doi: 10.1099/jgv.0.001861
|
| 5 |
Ziqiang Xia, Juzeng Zheng, Liang Zheng, Endian Zheng, Zhuolin Zou, Xiong Sheng, Jinming Wu. Effects of dyslipidemia on E antigen seroconversion of patients with chronic hepatitis B treated by nucleoside (acid) analogs. Lipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01582-x
|
| 6 |
Andrew Vaillant. Transaminase Elevations during Treatment of Chronic Hepatitis B Infection: Safety Considerations and Role in Achieving Functional Cure. Viruses 2021; 13(5): 745 doi: 10.3390/v13050745
|
| 7 |
Sabrina Pagano, Alessandra Magenta, Marco D’Agostino, Francesco Martino, Francesco Barillà, Nathalie Satta, Miguel A. Frias, Annalisa Ronca, François Mach, Baris Gencer, Elda Favari, Nicolas Vuilleumier. Anti-ApoA-1 IgGs in Familial Hypercholesterolemia Display Paradoxical Associations with Lipid Profile and Promote Foam Cell Formation. Journal of Clinical Medicine 2019; 8(12): 2035 doi: 10.3390/jcm8122035
|
| 8 |
Xiao-Feng Wang, Wen-Yu Wu, Gao-Kun Qiu, Hao Wang, Wen-Si Li, Yong-Li Wang, Qun-Qun Jiang, Mei-Fang Han, Qin Ning. Plasma lipidomics identifies novel biomarkers in patients with hepatitis B virus-related acute-on-chronic liver failure. Metabolomics 2017; 13(6) doi: 10.1007/s11306-017-1215-x
|
| 9 |
Maryam Naghib, Ashraf Kariminik, Mohammad Kazemi Arababadi. TLR2, as a Pathogen Recognition Receptor, Plays Critical Roles in Hepatitis B Outcome. Viral Immunology 2022; 35(1): 15 doi: 10.1089/vim.2021.0141
|
| 10 |
Evanthia Tourkochristou, Stelios F. Assimakopoulos, Konstantinos Thomopoulos, Markos Marangos, Christos Triantos. NAFLD and HBV interplay - related mechanisms underlying liver disease progression. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.965548
|
| 11 |
Olivier Diaz, Anne-Flore Legrand, Walid El-Orch, Florentine Jacolin, Vincent Lotteau, Christophe Ramière, Pierre-Olivier Vidalain, Laure Perrin-Cocon. Rôle du métabolisme cellulaire dans le contrôle des hépatites virales chroniques. médecine/sciences 2023; 39(10): 754 doi: 10.1051/medsci/2023125
|
| 12 |
Zhen Xun, Jin-Piao Lin, Can Liu, Jin-Lan Huang, Ye Shen, Si-Yi Xu, Wen-Nan Wu, Qi-Shui Ou. Association of Serum Total Cholesterol with Pegylated Interferon-α Treatment in HBeAg-Positive Chronic Hepatitis B Patients. Antiviral Therapy 2019; 24(2): 85 doi: 10.3851/IMP3282
|
| 13 |
Wenting Ke, Yanrong Zhou, Yinan Lai, Siwen Long, Liurong Fang, Shaobo Xiao. Porcine reproductive and respiratory syndrome virus nsp4 positively regulates cellular cholesterol to inhibit type I interferon production. Redox Biology 2022; 49: 102207 doi: 10.1016/j.redox.2021.102207
|
| 14 |
M. Gharehbeglou, S. Yazdani, K. White, M. R. Haeri, N. Masoumzadeh, Arif Siddiqui. Atorvastatin Rapidly Reduces Hepatitis B Viral Load in Combination with Tenofovir: A Prospective Clinical Trial. Canadian Journal of Infectious Diseases and Medical Microbiology 2022; 2022: 1 doi: 10.1155/2022/3443813
|
| 15 |
Yi-Xian Shi, Chen-Jie Huang, Zheng-Gang Yang. Impact of hepatitis B virus infection on hepatic metabolic signaling pathway. World Journal of Gastroenterology 2016; 22(36): 8161-8167 doi: 10.3748/wjg.v22.i36.8161
|
| 16 |
Danqing Hu, Hongwu Wang, Hai Wang, Yaqi Wang, Xiaoyang Wan, Weiming Yan, Xiaoping Luo, Qin Ning. Non-alcoholic hepatic steatosis attenuates hepatitis B virus replication in an HBV-immunocompetent mouse model. Hepatology International 2018; 12(5): 438 doi: 10.1007/s12072-018-9877-7
|
| 17 |
Ahmed Gaballah, Birke Bartosch. An Update on the Metabolic Landscape of Oncogenic Viruses. Cancers 2022; 14(23): 5742 doi: 10.3390/cancers14235742
|
| 18 |
Said A. Al-Busafi, Amna S. Al Balushi, Halima H. Al Shuaili, Dalia A. Mahmood, Abdullah M. Al Alawi. Prevalence of Non-Alcoholic Fatty Liver Disease and Its Impact on Fibrosis Risk in Inactive Chronic Hepatitis B Patients: Insights from a Cross-Sectional Study. Journal of Clinical Medicine 2024; 13(16): 4738 doi: 10.3390/jcm13164738
|
| 19 |
Yang Zheng, Kaijin Xu, Haiyang Hu, Mohamed S. Draz, Wei Wu, Lanjuan Li. Prevalence and Incidence of Non-alcohol Fatty Liver Disease in Chronic Hepatitis B Population in Southeast China: A Community-Based Study. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.683872
|
| 20 |
Olivier Diaz, Pierre-Olivier Vidalain, Christophe Ramière, Vincent Lotteau, Laure Perrin-Cocon. What role for cellular metabolism in the control of hepatitis viruses?. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1033314
|
| 21 |
Minghao Ha, Wei Xia, Dongxu Tang, Jianqiu Wu, Liping Sun, Wenjuan Shen, Zhongming Huang, Xiaolan Chen, Wenyan Shan. Hepatitis B e antigen-positive and high levels of alanine aminotransferase are associated with prevalence of metabolic syndrome in chronic HBV patients. Obesity Research & Clinical Practice 2016; 10(6): 673 doi: 10.1016/j.orcp.2015.10.004
|
| 22 |
Zhiqi Guo, Xiaoyi Lv, Long Yu, Zhaoxia Zhang, Shengwei Tian. Identification of hepatitis B using Raman spectroscopy combined with gated recurrent unit and multiscale fusion convolutional neural network. Spectroscopy Letters 2020; 53(4): 277 doi: 10.1080/00387010.2020.1737944
|
| 23 |
Christopher Groth, Svea Wupper, Gnimah Eva Gnouamozi, Katrin Böttcher, Adelheid Cerwenka. Intrinsic Immune Response of HBV/HDV-Infected Cells and Corresponding Innate (Like) Immune Cell Activation. Livers 2024; 4(4): 562 doi: 10.3390/livers4040040
|
| 24 |
Goutham Venkata Naga Davuluri, Chien-Chin Chen, Yen-Cheng Chiu, Hung-Wen Tsai, Hung-Chih Chiu, Yuh-Ling Chen, Pei-Jane Tsai, Wan-Ting Kuo, Nina Tsao, Yee-Shin Lin, Chih-Peng Chang. Autophagy Drives Galectin-1 Secretion From Tumor-Associated Macrophages Facilitating Hepatocellular Carcinoma Progression. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.741820
|
| 25 |
Yaqi Wang, Ting Wu, Danqing Hu, Xinxin Weng, Xiaojing Wang, Pei-Jer Chen, Xiaoping Luo, Hongwu Wang, Qin Ning. Intracellular hepatitis B virus increases hepatic cholesterol deposition in alcoholic fatty liver via hepatitis B core protein. Journal of Lipid Research 2018; 59(1): 58 doi: 10.1194/jlr.M079533
|
| 26 |
Vahid Bagheri, Azam Askari, Mohammad Kazemi Arababadi, Derek Kennedy. Can Toll-Like Receptor (TLR) 2 be considered as a new target for immunotherapy against hepatitis B infection?. Human Immunology 2014; 75(6): 549 doi: 10.1016/j.humimm.2014.02.018
|
| 27 |
Jianbin Zhang, Shuangzhe Lin, Daixi Jiang, Mengting Li, Yuanwen Chen, Jun Li, Jiangao Fan. Chronic hepatitis B and non‐alcoholic fatty liver disease: Conspirators or competitors?. Liver International 2020; 40(3): 496 doi: 10.1111/liv.14369
|
| 28 |
Elisabeth M. Haberl, Thomas S. Weiss, Georg Peschel, Kilian Weigand, Nikolai Köhler, Josch K. Pauling, Jürgen J. Wenzel, Marcus Höring, Sabrina Krautbauer, Gerhard Liebisch, Christa Buechler. Liver Lipids of Patients with Hepatitis B and C and Associated Hepatocellular Carcinoma. International Journal of Molecular Sciences 2021; 22(10): 5297 doi: 10.3390/ijms22105297
|
| 29 |
Xin Wang, Shengwei Tian, Long Yu, Xiaoyi Lv, Zhaoxia Zhang. Rapid screening of hepatitis B using Raman spectroscopy and long short-term memory neural network. Lasers in Medical Science 2020; 35(8): 1791 doi: 10.1007/s10103-020-03003-4
|
| 30 |
Je-Wen Liou, Hemalatha Mani, Jui-Hung Yen. Viral Hepatitis, Cholesterol Metabolism, and Cholesterol-Lowering Natural Compounds. International Journal of Molecular Sciences 2022; 23(7): 3897 doi: 10.3390/ijms23073897
|
| 31 |
Idrees Suliman, Noha Abdelgelil, Farah Kassamali, Tarek I. Hassanein. The Effects of Hepatic Steatosis on the Natural History of HBV Infection. Clinics in Liver Disease 2019; 23(3): 433 doi: 10.1016/j.cld.2019.05.001
|
| 32 |
Jun Wang, Hongzhou Lu, Qian Li. Hepatic macrophage niche: a bridge between HBV-mediated metabolic changes with intrahepatic inflammation. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1414594
|